Drug Discovery

Mila has partnered with SEVO Bioscience to develop SYNTIA, an AI-driven protein design platform for engineered microalgae products and vaccines.

A paper from NVIDIA, Moderna and Yale reviews how quantum machine learning could improve molecular property prediction, using GPU-accelerated simulation.

NVIDIA has released a NIM Agent Blueprint for generative AI-based virtual screening, aimed at making drug discovery faster and cheaper.

AlphaFold 3 from Google DeepMind and Isomorphic Labs predicts the structures of proteins, DNA, RNA and ligands, with a free server for researchers.

Mila and Sorintellis partner to use AI for optimising decision-making in clinical drug development, aiming to accelerate access to new therapies.